Steris Plc Intrinsic Value Calculator – STERIS PLC Demonstrates Market Resilience with Slight Dip in Finishing Price at 227.15
October 17, 2024
🌥️Trending News
STERIS PLC ($NYSE:STE) is a leading global provider of infection prevention, decontamination, and health science technologies. The company’s products and services are used in hospitals, pharmaceutical and biotechnology industries, research laboratories, and other healthcare facilities. With a strong focus on preventing the spread of infectious diseases, STERIS PLC has become a vital player in the healthcare industry. On DATE, STERIS PLC’s stock price finished at 227.15, showing a slight decrease of -0.03. While this may seem like a dip in value, it actually demonstrates the company’s market resilience. In the face of challenging economic conditions, STERIS PLC has proven its ability to weather the storm and maintain a strong position in the market. One factor contributing to STERIS PLC’s market resilience is its diversified portfolio of products and services. The company offers a wide range of solutions for infection prevention, sterilization, and contamination control. This diversification helps to mitigate risks and minimize the impact of market fluctuations on the company’s overall performance.
Additionally, STERIS PLC has a strong track record of delivering consistent and reliable financial results. Furthermore, STERIS PLC has demonstrated a commitment to innovation and growth through strategic investments and acquisitions. This move not only strengthens STERIS PLC’s product offerings but also increases its global reach and customer base. In conclusion, while STERIS PLC’s finishing price may have shown a slight dip, it is a reflection of the broader market conditions and should not overshadow the company’s overall resilience. With a diverse portfolio, strong financial performance, and strategic investments, STERIS PLC is well-positioned to continue its growth and success in the healthcare industry.
Market Price
Steris PLC, a leading provider of infection prevention and other healthcare products, demonstrated its market resilience on Friday with a slight dip in finishing price at $227.15. Despite the dip, the stock opened at $227.23 and closed at $226.9, showing a 0.33% increase from the previous closing price of $226.16. This small decrease in finishing price may be attributed to the overall volatility of the market, as the company’s stock has shown a consistent upward trend in recent months. This resilience in the face of market fluctuations highlights the stability and strength of STERIS PLC as a company. The slight dip in finishing price also does not reflect any negative news or developments within the company. In fact, STERIS PLC has been making positive strides in its business operations and growth.
Additionally, STERIS PLC has been expanding its product offerings and global presence through strategic acquisitions and partnerships. This has helped to diversify its revenue streams and establish a strong foothold in key markets. Furthermore, the company’s strong financial position and consistent performance make it an attractive investment option for investors looking for stability in a volatile market. With a track record of delivering value to shareholders through consistent growth and dividends, STERIS PLC remains a strong contender in the healthcare industry. With continued strategic initiatives and a strong financial position, the company is well-equipped to navigate through market fluctuations and continue delivering value to its stakeholders. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Steris Plc. More…
| Total Revenues | Net Income | Net Margin |
| 5.41k | 566.84 | 10.5% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Steris Plc. More…
| Operations | Investing | Financing |
| 934.27 | -869.33 | -133.36 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Steris Plc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 11.44k | 5.01k | 62.53 |
Key Ratios Snapshot
Some of the financial key ratios for Steris Plc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 20.9% | 13.4% | 15.1% |
| FCF Margin | ROE | ROA |
| 11.0% | 8.3% | 4.5% |
Analysis – Steris Plc Intrinsic Value Calculator
First and foremost, my analysis focuses on examining the overall health and performance of STERIS PLC. This includes looking at various financial metrics such as revenue, expenses, and profitability, as well as assessing the company’s market position and potential for growth. One important aspect of my analysis is determining the fair value of STERIS PLC’s shares. After careful consideration and utilizing our proprietary Valuation Line, I have determined that the fair value of the company’s shares is around $246.4. This calculation takes into account a variety of factors, including current market conditions and the company’s financial outlook. Currently, STERIS PLC’s stock is trading at $226.9, which means it is undervalued by 7.9% based on our fair value calculation. This presents a potential opportunity for investors looking to purchase the stock at a discount. With its current stock price undervalued, it may be a good time for investors to consider adding STERIS PLC to their portfolio. More…
Peers
The company’s main competitors are Fonar Corp, Stryker Corp, and Dynatronics Corp.
– Fonar Corp ($NASDAQ:FONR)
Fonar Corporation is a holding company, which engages in the design, manufacture, sale, and service of magnetic resonance imaging (MRI) scanners. It operates through the following segments: Upright Multi-Position MRI; Stand-Up MRI; and Recurring Revenue. The Upright Multi-Position MRI segment designs, manufactures, and sells Upright Multi-Position MRI scanners. The Stand-Up MRI segment designs, manufactures, sells, and services Stand-Up MRI scanners. The Recurring Revenue segment provides service contracts, technical support, and parts sales. The company was founded by Stanley C. Krulick in 1978 and is headquartered in Melville, NY.
– Stryker Corp ($NYSE:SYK)
Stryker Corporation is one of the world’s leading medical technology companies. It offers a wide range of medical devices and services, including orthopedics, neurotechnology, and medical imaging. It has more than 87,000 employees worldwide.
– Dynatronics Corp ($NASDAQ:DYNT)
Dynatronics Corp is a medical device company that manufactures and markets physical therapy products and solutions. The company’s products are used by physical therapists, occupational therapists, athletic trainers, and other healthcare professionals. Dynatronics Corp has a market cap of 8.73M as of 2022, a Return on Equity of -10.7%. The company’s products are sold in the United States and internationally.
Summary
The market resilience of STERIS PLC was evident as the company finished the trading session at a weak stock price of 227.15, down by -0.03. Despite this, the company’s ability to withstand market fluctuations and maintain its position in the market showcases its strong fundamentals. Investors can see this as an opportunity to invest in a company with a steady performance and potential for growth.
It is also noteworthy that STERIS PLC managed to stay afloat during a challenging time for the market, highlighting its ability to weather uncertainties. This makes it a promising option for long-term investments.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
